Chronic ethanol treatment potentiates ethanol‐induced increases in interstitial nucleus accumbens endocannabinoid levels in rats
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
We employed in vivo microdialysis to characterize the effect of an ethanol challenge injection on endocannabinoid levels in the nucleus accumbens of ethanol‐naïve and chronic ethanol‐treated rats. Ethanol (0.75 and 2 g/kg, i.p.) dose‐dependently increased dialysate 2‐arachidonoylglycerol (to a maximum 157 ± 20% of baseline) and decreased anandamide (to a minimum 52 ± 9% of baseline) in ethanol‐naïve rats. The endocannabinoid clearance inhibitor N‐(4‐hydrophenyl) arachidonoylamide (AM404; 3 mg/kg) potentiated ethanol effects on 2‐arachidonoylglycerol levels but did not alter ethanol‐induced decreases in anandamide. AM404 alone did not alter dialysate levels of either endocannabinoid. Then, we characterized the effect of ethanol challenge on nucleus accumbens endocannabinoid levels in rats previously maintained on an ethanol‐containing liquid diet. Ethanol challenge produced a greater and more prolonged increase in 2‐arachidonoylglycerol (to a maximum 394 ± 135% of baseline) in ethanol‐experienced than in ethanol‐naïve rats. The profile in ethanol‐experienced rats was similar to that produced by AM404 pre‐treatment in ethanol‐naïve rats. AM404 in ethanol‐experienced rats led to a further enhancement in the 2‐arachidonoylglycerol response to ethanol challenge (to a maximum 704 ± 174% of baseline). Our findings demonstrate that ethanol‐induced increases in nucleus accumbens 2‐arachidonoylglycerol are potentiated in animals with a history of ethanol consumption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568 · cited 2×
“Ryberg et al. (2007) have shown that 2-AG has a greater potency as an agonist at GPR55 (EC50 = 3 nM) than CB1 (EC50 = 519 nM) or CB2 (EC50 = 618 nM) receptors.”
BackgroundKozak, K. R., Rowlinson, S. W., & Marnett, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007088200 · Cited by 390
Roberto, M., Schweitzer, P., Madamba, S. G., Stouffer, D. G., Parsons, L. H., & Siggins, G. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5077-03.2004 · Cited by 312 · cited 2×
“…in EtOH-experienced mice (Szumlinski et al. 2007; Kapasova and Szumlinski 2008), and cellular physiology and microdialysis studies have found evidence of increased glutamate transmission in the central and basolateral nuclei of the amygdala following CET (Roberto et al. 2004; Läck et al. 2007).”
BackgroundSelf-citationCaillé, S., Alvarez-Jaimes, L., Polis, I., Stouffer, D. G., & Parsons, L. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4403-06.2007 · Cited by 280 · cited 10×
“As previously described (Walker et al. 1999; Caillé et al. 2007; Ferrer et al. 2007), inclusion of hydroxypropyl-b-cyclodextrin substantially increases the recovery of EC by microdialysis.”
BackgroundMethodInfluentialSelf-citationVallés, S. L., Blanco, A. M., Pascual, M., & Guerri, C. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00079.x · Cited by 271
Rademacher, D. J., Meier, S. E., Shi, L., Vanessa Ho, W.-S., Jarrahian, A., & Hillard, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.012 · Cited by 233
Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400997101 · Cited by 230 · cited 1×
“Systemic AM404 administration increases AEA levels in rat plasma and bulk levels in tissue from some brain areas, with lesser increases in brain 2-AG levels (Beltramo et al. 1997; Beltramo and Piomelli 2000; Giuffrida et al. 2000; Fegley et al. 2004; Di et al. 2005; Bortolato et al. 2006).”
BackgroundGorzalka, B. B., Hill, M. N., & Hillard, C. J. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.004 · Cited by 211
Sang, N., Zhang, J., & Chen, C. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105569 · Cited by 89 · cited 2×
“Prostaglandin ester-2 increases the frequency of miniature inhibitory postsynaptic currents (mIPSCs) (Sang et al. 2006) and miniature excitatory post-synaptic currents (mEPSCs) (Sang et al.”
Background
Cited by
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4004 · Cited by 481
Self-citationEndogenous cannabinoid signaling is essential for stress adaptation
Hill, M. N., McLaughlin, R. J., Bingham, B., Shrestha, L., Lee, T. T. Y., Gray, J. M., Hillard, C. J., Gorzalka, B. B., & Viau, V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914661107 · Cited by 349
Nealey, K. A., Smith, A. W., Davis, S. M., Smith, D. G., & Walker, B. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.012 · Cited by 133
“All compounds were soluble in aCSF (pH 7.2–7.4 was composed of 145 mM NaCl, 2.8 mM KCl, 1.2 mM MgCl2, 1.2 mM CaCl2, 5.4 mM d-Glucose and 0.25 mM ascorbic acid; Alvarez-Jaimes et al. 2009) at the concentrations listed in section 2.”
MethodInfluentialSánchez-Marín, L., Flores-López, M., Pastor, A., Gavito, A. L., Suárez, J., de la Torre, R., Pavón, F. J., Rodríguez de Fonseca, F., & Serrano, A. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110460 · Cited by 33
Sanchez-Marin, L., Gavito, A. L., Decara, J., Pastor, A., Castilla-Ortega, E., Suarez, J., de la Torre, R., Pavon, F. J., Rodriguez de Fonseca, F., & Serrano, A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.012 · Cited by 16
Metadata
- Authors
- Alvarez‐Jaimes, L., Stouffer, D. G., & Parsons, L. H.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2009-09-14
- Volume
- 111
- Issue
- 1
- Pages
- 37-48
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1973305416
- Cited by
- 62
- References
- 9
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic ethanol treatment potentiates ethanol‐induced increases in interstitial nucleus accumbens endocannabinoid levels in rats. https://app.cochat.ai/papers/10.1111/j.1471-4159.2009.06301.x
- The paper
- Alvarez‐Jaimes, L., Stouffer, D. G., & Parsons, L. H. (2009). Chronic ethanol treatment potentiates ethanol‐induced increases in interstitial nucleus accumbens endocannabinoid levels in rats. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2009.06301.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.